BIOMAT Database Logo BIOMAT Database Logo

[Clinical effect of recombinant human granulocyte colony-stimulating factor on aplastic anemia]. 1990

S Asano, and K Hirashima, and Y Yoshida, and F Takaku, and T Miyazaki, and M Omine, and S Furusawa, and T Abe, and M Mori, and S Arimori
Department of Hematology-Oncology, Institute of Medical Science, University of Tokyo.

The effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on neutropenia was studied in 30 patients with aplastic anemia (AA). RhG-CSF was administered intravenously daily at a dose of 2, 5, 10, or 20 micrograms/kg/day for more than 7 days. In the patients whose absolute neutrophil counts (ANC) were more than 0.1 X 10(9)/l, the rhG-CSF injections at greater than or equal to 5 micrograms/kg/day caused rapid and selective elevation of ANC which maintained during the injection period. Most of the patients were well tolerated, and minor side effects were observed in only 3 patients. These findings suggest that daily injections of rhG-CSF at a dose of greater than or equal to 5 micrograms/kg/day may be an effective strategy for the treatment of bacterial and/or fungal infections in AA patients.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009503 Neutropenia A decrease in the number of NEUTROPHILS found in the blood. Neutropenias
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S Asano, and K Hirashima, and Y Yoshida, and F Takaku, and T Miyazaki, and M Omine, and S Furusawa, and T Abe, and M Mori, and S Arimori
Treatment of aplastic anemia in children with recombinant human granulocyte colony-stimulating factor.
March 1991, Blood,
S Asano, and K Hirashima, and Y Yoshida, and F Takaku, and T Miyazaki, and M Omine, and S Furusawa, and T Abe, and M Mori, and S Arimori
Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factor.
February 1989, Blood,
S Asano, and K Hirashima, and Y Yoshida, and F Takaku, and T Miyazaki, and M Omine, and S Furusawa, and T Abe, and M Mori, and S Arimori
Cyclosporine and recombinant granulocyte colony-stimulating factor in severe aplastic anemia.
September 1990, The New England journal of medicine,
S Asano, and K Hirashima, and Y Yoshida, and F Takaku, and T Miyazaki, and M Omine, and S Furusawa, and T Abe, and M Mori, and S Arimori
Combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in aplastic anemia.
January 1995, American journal of hematology,
S Asano, and K Hirashima, and Y Yoshida, and F Takaku, and T Miyazaki, and M Omine, and S Furusawa, and T Abe, and M Mori, and S Arimori
Granulocyte colony-stimulating factor and severe aplastic anemia.
May 2007, Blood,
S Asano, and K Hirashima, and Y Yoshida, and F Takaku, and T Miyazaki, and M Omine, and S Furusawa, and T Abe, and M Mori, and S Arimori
Methimazole-induced severe aplastic anemia: unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor.
February 1997, Thyroid : official journal of the American Thyroid Association,
S Asano, and K Hirashima, and Y Yoshida, and F Takaku, and T Miyazaki, and M Omine, and S Furusawa, and T Abe, and M Mori, and S Arimori
Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.
April 1989, Seminars in hematology,
S Asano, and K Hirashima, and Y Yoshida, and F Takaku, and T Miyazaki, and M Omine, and S Furusawa, and T Abe, and M Mori, and S Arimori
Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
January 1990, Progress in clinical and biological research,
S Asano, and K Hirashima, and Y Yoshida, and F Takaku, and T Miyazaki, and M Omine, and S Furusawa, and T Abe, and M Mori, and S Arimori
Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor.
December 1988, The New England journal of medicine,
S Asano, and K Hirashima, and Y Yoshida, and F Takaku, and T Miyazaki, and M Omine, and S Furusawa, and T Abe, and M Mori, and S Arimori
[Late effects of treatment with recombinant human granulocyte colony-stimulating factor in patients with aplastic anemia].
May 1997, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!